BrightFocus Foundation launches two national public service announcements encouraging eye exams to save sight from macular ...

Neil Laird says it is packed with nutrients that protect eyesight and reduce the risk of age-related macular degeneration ...

OLN324 targets both VEGF and Ang2, the same mechanism of action as Roche’s Vabysmo, the Swiss giant’s multi-blockbuster ...

Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing novel adult retinal pigment epithelial stem ...

During his tenure at Roche's Genentech, ophthalmologist Jason Ehrlich, M.D., Ph.D., supported the development of the ...

An analysis of pivotal phase 3 trials shows supplements to arrest age-related macular degeneration have no effect on ...

K8 was found to reduce geographic atrophy lesion area growth by more than 50% in its first human clinical trial of the drug.

LumiThera's key innovation is a device for use by ophthalmologists that improves vision and slows its loss, with a focus on ...

A warm compress can soften and unclog the flow of oil. Try a microwavable eye mask twice a day for about 10 minutes. If all ...

Backed by a trio of top venture firms, Ollin is working on a pair of medicines it believes can one-up Roche’s Vabysmo and Amgen’s Tepezza.

The contracting and deployment have been facilitated by Human Bytes, a Nordic specialist in the safe and ethical implementation and scaling of AI for healthcare and a distributor for the EyeArt system ...

Discover how AI-based eye scans are transforming healthcare by detecting high blood sugar and heart disease through ...